D-105

Active substance: BOS TAURUS ADRENAL GLAND, APIS MELLIFERA, ARSENIC TRIOXIDE, LYTTA VESICATORIA, BOS TAURUS LYMPH VESSEL, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, TOXICODENDRON PUBESCENS LEAF, URTICA URENS, PYRIDOXINE HYDROCHLORIDE, ASCORBIC ACID

SOLUTION · BOS TAURUS ADRENAL GLAND 6 [hp_X]/mL, APIS MELLIFERA 12 [hp_X]/mL, ARSENIC TRIOXIDE 30 [hp_X]/mL, LYTTA VESICATORIA 12 [hp_X]/mL, BOS TAURUS LYMPH VESSEL 6 [hp_X]/mL, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 6 [hp_X]/mL, TOXICODENDRON PUBESCENS LEAF 12 [hp_X]/mL, URTICA URENS 12 [hp_X]/mL, PYRIDOXINE HYDROCHLORIDE 3 [hp_X]/mL, ASCORBIC ACID 3 [hp_X]/mL

United StatesActive

Marketing holder: DNA Labs, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries

Source: openFDA NDC
Countries with the substance registered: 2

Composition

BOS TAURUS ADRENAL GLAND · 6 [hp_X]/mL
APIS MELLIFERA · 12 [hp_X]/mL
ARSENIC TRIOXIDE · 30 [hp_X]/mL
LYTTA VESICATORIA · 12 [hp_X]/mL
BOS TAURUS LYMPH VESSEL · 6 [hp_X]/mL
MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE · 6 [hp_X]/mL
TOXICODENDRON PUBESCENS LEAF · 12 [hp_X]/mL
URTICA URENS · 12 [hp_X]/mL
PYRIDOXINE HYDROCHLORIDE · 3 [hp_X]/mL
ASCORBIC ACID · 3 [hp_X]/mL

Products containing arsenic trioxide in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

Country	Products
EU 4	Arsenic trioxide Accord arsenic trioxide EMEA/H/C/005175 Accord Healthcare S.L.U. Arsenic trioxide medac arsenic trioxide EMEA/H/C/005218 medac Gesellschaft für klinische Spezialpräparate mbH Trisenox arsenic trioxide EMEA/H/C/000388 Teva B.V. Arsenic trioxide Mylan arsenic trioxide EMEA/H/C/005235 Mylan Ireland Limited

Registration

Registration number: 58264-0111
Registration status: Active
Dispensing: Over the counter
Route: SUBLINGUAL

Sources

product · openFDA NDC · 58264-0111 · Verified 2026-10-09 · open in source
registration_status · openFDA NDC · 58264-0111 · Verified 2026-10-09 · open in source
ingredients.0 · openFDA NDC · 58264-0111 · Verified 2026-10-09 · open in source
ingredients.1 · openFDA NDC · 58264-0111 · Verified 2026-10-09 · open in source
ingredients.2 · openFDA NDC · 58264-0111 · Verified 2026-10-09 · open in source
ingredients.3 · openFDA NDC · 58264-0111 · Verified 2026-10-09 · open in source
ingredients.4 · openFDA NDC · 58264-0111 · Verified 2026-10-09 · open in source
ingredients.5 · openFDA NDC · 58264-0111 · Verified 2026-10-09 · open in source
ingredients.6 · openFDA NDC · 58264-0111 · Verified 2026-10-09 · open in source
ingredients.7 · openFDA NDC · 58264-0111 · Verified 2026-10-09 · open in source
ingredients.8 · openFDA NDC · 58264-0111 · Verified 2026-10-09 · open in source
ingredients.9 · openFDA NDC · 58264-0111 · Verified 2026-10-09 · open in source